肝硬化患者的疫苗接种:一个被忽视的主题
Tommaso Stroffolini1, Giacomo Stroffolini2
1Department of Tropical and Infectious Diseases, Policlinico Umberto I, 00161 Rome, Italy.
Vaccines
|July 27, 2024
概括
肝硬化患者的免疫力减弱,使他们容易受到感染. 疫苗接种对于预防严重疾病和死亡至关重要,尽管这些人的抗体反应减少了.
科学领域:
- 免疫学 免疫学 免疫学
- 肝病学 肝病学是一种肝病学.
- 公共卫生 公共卫生
背景情况:
- 肝硬化患者表现出受损的先天性和适应性免疫力,增加对感染的易感性.
- 肝硬化时免疫功能受损导致接种疫苗后抗体反应减弱.
- 尽管反应不佳,但主要的肝脏协会 (AASLD,EASL) 建议接种疫苗,以减轻严重的结果和死亡率.
研究的目的:
- 为了强调肝硬化患者接种疫苗的重要性.
- 解决这个脆弱人群中疫苗覆盖率低于最佳的问题.
- 推改善疫苗接种率和有效性的策略.
主要方法:
- 审查当前文献和关于肝病疫苗接种的指导方针.
- 对导致肝硬化患者疫苗接种率低的因素的分析.
- 综合建议,以提高疫苗的有效性和可访问性.
主要成果:
- 疫苗有效地减少了肝硬化患者的严重后果和死亡,即使抗体反应有限.
- 疫苗覆盖率仍然低于最佳水平,尽管肝脏协会提出了强有力的建议.
- 慢性肝病的早期疫苗接种与更高的疗效有关.
结论:
- 疫苗接种对于肝硬化患者至关重要,以预防严重感染和死亡.
- 需要采取战略,包括改善患者咨询,打击错误信息和消除接入障碍,以增加疫苗覆盖率.
- 在慢性肝病的早期阶段及时接种疫苗对于最大限度地获得益处至关重要.
相关概念视频
Esophageal Varices-II: Clinical Features and Management
57
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
57
Diseases of the Liver and Gallbladder
499
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
499
Vaccinations
44.3K
Overview
44.3K
Pleural Effusion II: Symptoms and Management
161
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
161
Cancer Vaccines
347
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
347


